Chris Kosmidis
@ckosmidis
Followers
955
Following
1K
Media
20
Statuses
636
Infectious Diseases Physician and Researcher, University of Manchester. Interested in all aspergillosis clinical syndromes, invasive, allergic and chronic.
Manchester, UK
Joined May 2009
Dear friends:.If you diagnose patients with chronic pulmonary aspergillosis, you can help us! Short survey on how you use Aspergillus IgG in #CPA. Your answers will help understand how CPA is diagnosed globally! @eurconfmedmycol @CPAnetResearch @MFT_NAC .
forms.office.com
0
6
5
RT @ProfJDChalmers: New in @ERSpublications @MereteLong from @dundeeuni discussing interesting new data on IL-33 in COPD from FRONTIER-4.IL….
0
20
0
RT @MFT_NAC: Listening to other people's experiences helps patients come to terms with their diagnosis and feel less alone. @TGBermingham h….
0
2
0
Increasing interest in the role of Aspergillus in bronchiectasis outcomes. Aspergillus serology should become part of routine care, and management should be individualised. @MFT_NAC @BTSrespiratory @ProfJDChalmers.
New findings highlight a need to integrate #Aspergillus serologies into routine #bronchiectasis care and adopt a phenotype-driven, personalized approach to fungal surveillance and treatment. 🔗 Read more in CHEST Physician:
0
10
19
RT @MFT_NAC: 📢 Calling all respiratory & infectious disease clinicians:.Have a patient with chronic pulmonary aspergillosis (CPA) starting….
0
3
0
RT @FungalDoc: You can now buy both of our new books for 25% off using the code ID25. You can buy the other ID books too. .
us.elsevierhealth.com
With complete coverage of the most frequently encountered concepts and conditions in infectious disease, Comprehensive Review of Infectious Diseases, Second Edition, is perfect for board review or...
0
10
0
RT @FungalDoc: We are recruiting Transplant ID physicians into a vibrant and diverse group with active research and patient care. Looking….
0
10
0
🔬 Delighted to offer a PhD @OfficialUoM: personalise antifungal therapy for chronic lung disease. Work on big-data + precision-medicine trial to boost outcomes in asthma/COPD/bronchiectasis. Clinicians & scientists welcome. Apply year-round 👉 @MFT_NAC.
findaphd.com
PhD Project - Personalised approach to antifungal treatment in chronic fungal lung disease at The University of Manchester, listed on FindAPhD.com
0
3
11
The exact immune dysfunction in patients with chronic pulmonary aspergillosis is not known. In our recent paper we show that this dysfunction is centered around dendritic cells, leading to reduced IL12 production. @MFT_NAC @NACincas
pubmed.ncbi.nlm.nih.gov
Our findings suggest that immune dysfunction in CPA involves DC and monocyte impairments, potentially contributing to IFNγ deficiency through reduced IL-12 production and co-stimulatory capacity in...
0
4
11
RT @Fungaldx: Dear Colleagues,.We are pleased to announce FungalDx26, which will take place on December 2–3, 2026, in Bethesda, MD, USA. D….
fungaldx.com
Fungal Dx 26 📅 Dec 2–3, 2026 📍 Bethesda, MD, USA 🌐 www.fungaldx.com
0
5
0
RT @MFT_NAC: If you’re at #BTSSummer2025 come to the @MFT_NAC stall to see how we can help YOU support chronic aspergillosis patients (even….
0
3
0
RT @MFT_NAC: Who's going to #BTSSummer2025 tomorrow?. Come and say hi 👋 to the National Aspergillosis Centre team at stand G (turn left jus….
0
1
0
RT @MFT_NAC: 📢 Calling all respiratory & infectious disease clinicians:.Have a patient with chronic pulmonary aspergillosis (CPA) starting….
0
3
0
RT @MFT_NAC: 📢 Calling all respiratory & infectious disease clinicians:.Have a patient with chronic pulmonary aspergillosis (CPA) starting….
0
2
0
Heading to @ISHAM_Mycology meeting! Hope to see many of you there!.Looking forward to contributing to sessions on chronic fungal lung disease on Wednesday and serological diagnosis of CPA on Friday. @MFT_NAC.
0
2
11
RT @NormanRhijn: Brazilian TV had a long section about fungal pathogens, AMR and the future risks of fungi🔥thoroughly enjoyed the filming d….
0
8
0
RT @forestcita: Don't forget to register and send your abstract for #BSMM2025 @NorwichCC @Assembly_House DEADLINE I….
0
5
0
RT @MFT_NAC: CPA affects ~3,600 people in the UK. Mortality can reach 40% at 5 years. Current treatment = long-term azoles with limited eff….
0
4
0
RT @MFT_NAC: 📢 Calling all respiratory & infectious disease clinicians:.Have a patient with chronic pulmonary aspergillosis (CPA) starting….
0
3
0
Really happy to help raise awareness about chronic pulmonary aspergillosis with @EuropeanLung @CPAnetResearch @MFT_NAC .
europeanlung.org
This month, we spoke with Chris Kosmidis, Clinical Director of the National Aspergillosis Centre and member of the Chronic Pulmonary Aspergillosis Network (CPAnet).
0
4
8
Study recruiting now. Respiratory and ID clinicians: if you start patients on azoles for chronic aspergillosis they may be eligible to also receive interferon gamma via our RCT. Our preliminary data shows reduction in flares with IFNg @MFT_NAC.
💬 “First reaction is to encourage patients to chase the chance of having Gamma Interferon.”.– A CPA patient reflecting on past trial experience. Encourage your patients to take part in the INCAS trial and help build the future of CPA care. 📨 Contact NAC for referral info.#C .
0
0
2